CardiAQ Valve Technologies Wraps Up $37.3M Round

CardiAQ Valve Technologies Inc., a medical device company developing technologies for “percutaneous mitral heart valve replacement,” has raised $37.3 million in a second round of funding. OrbiMed led the round and was joined by Versant Ventures, Advent Life Sciences and existing investors. The latest funding incorporates conversion of a 2011 bridge financing, the company said in a press release.

North AmericaUSBriefs